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Type II toxin-antitoxin (TA) systems are most commonly composed of two genes
encoding a stable toxin, which harms the cell, and an unstable antitoxin that can
inactivate it. TA systems were initially characterized as selfish elements, but have recently
gained attention for regulating general stress responses responsible for pathogen
virulence, formation of drug-tolerant persister cells and biofilms—all implicated in
causing recalcitrant chronic infections. We use a bioinformatics approach to explore the
distribution and evolution of type II TA loci of the opportunistic pathogen, Pseudomonas
aeruginosa, across longitudinally sampled isolates from cystic fibrosis lungs. We identify
their location in the genome, mutations, and gain/loss during infection to elucidate their
function(s) in stabilizing selfish elements and pathogenesis. We found (1) 26 distinct TA
systems, where all isolates harbor four in their core genome and a variable number
of the remaining 22 on genomic islands; (2) limited mutations in core genome TA
loci, suggesting they are not under negative selection; (3) no evidence for horizontal
transmission of elements with TA systems between clone types within patients, despite
their ability to mobilize; (4) no gain and limited loss of TA-bearing genomic islands, and
of those elements partially lost, the remnant regions carry the TA systems supporting
their role in genomic stabilization; (5) no significant correlation between frequency of TA
systems and strain ability to establish as chronic infection, but those with a particular TA,
are more successful in establishing a chronic infection.
Keywords: toxin-antitoxin system, Pseudomonas aeruginosa, cystic fibrosis, infection, longitudinal studies,
chronic infection, genomic islands, integrative and conjugative elements
INTRODUCTION
Bacterial genomes contain flexible regions that vary in the extent to which they serve their own
selfish interests to ensure transmission or confer a selective advantage to the cell (Doolittle, 2005;
Lawrence and Hendrickson, 2005). Type II toxin-antitoxin (TA, hereafter used only to refer to
type II) systems are one such example. They are comprised of a typically bicistronic operon
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encoding two proteins: a stable toxin that harms the host cell,
and its cognate unstable antitoxin that inactivates the toxin by
binding to it (Gerdes et al., 2005). TA systems are near ubiquitous
and highly diverse in bacterial species (Pandey and Gerdes, 2005;
Shao et al., 2011). They were first discovered and described for
their ability to stabilize plasmids by selectively killing plasmid-
free daughter cells (Gerdes et al., 1986). This mechanism is
termed post-segregational killing and is a result of the differential
stability of the toxin and antitoxin: if the plasmid is lost, the
antitoxin is no longer produced, and subsequently the toxin can
interact with its cellular target (Gerdes et al., 1986; Yarmolinsky,
1995). In such cases, TA systems act as selfish elements that
ensure inheritance of self and neighboring genes.
Subsequently, TA systems have been identified in abundance
on bacterial chromosomes where they may serve different
functions (Tsilibaris et al., 2007; Saavedra De Bast et al.,
2008). Compatible with the plasmid stabilization hypothesis,
TA systems have been found to stabilize chromosomal mobile
elements and genomic islands on which they reside, such
as integrative conjugative elements (ICEs) and super-integron
cassettes (Pandey and Gerdes, 2005; Christensen-Dalsgaard and
Gerdes, 2006; Mazel, 2006; Qiu et al., 2006; Szekeres et al., 2007;
Tsilibaris et al., 2007; Wozniak andWaldor, 2009). However, this
is not the case for TA systems on other chromosomal regions
(Wilbaux et al., 2007). For example, TA systems residing in the
core genome are receiving growing interest for their role in
the development of recalcitrant chronic infections (Shah et al.,
2006; Lewis, 2008; Singh et al., 2009; Wang and Wood, 2011;
Lobato-Marquez et al., 2016).
TA systems have been implicated as particularly important in
the bacterial general stress response (Buts et al., 2005; Gerdes
et al., 2005; Ramage et al., 2009). However, Tsilibaris et al. (2007)
show that the TA systems of Escherichia coli did not contribute
to the bacterial stress response or give cells a selective advantage
when in stressful conditions. TA-induced stress-regulation is
increasingly studied in pathogens as a mechanism for enhancing
virulence (Ramage et al., 2009; Norton and Mulvey, 2012; Ren
et al., 2012, 2014; De La Cruz et al., 2013); inducing a reversible
bacteriostatic persister state in response to antibiotic treatment
or host immunity; rendering cells multidrug tolerant or resistant
to macrophages (Christensen et al., 2001, 2003; Lewis, 2008;
Wang and Wood, 2011; Yamaguchi et al., 2011; Fasani and
Savageau, 2013; Helaine et al., 2014; Helaine and Kugelberg, 2014;
Maisonneuve and Gerdes, 2014; Page and Peti, 2016; Vogwill
et al., 2016); and inducing biofilm formation (Gonzalez Barrios
et al., 2006; Kim et al., 2009; Wang and Wood, 2011). It has
been shown that pathogenic strains of chronic infections carry
more TA systems than related non-pathogenic species (Ramage
et al., 2009; Georgiades and Raoult, 2011; Sala et al., 2014; Lobato-
Marquez et al., 2015), however, Pandey and Gerdes (2005) found
that obligate intracellular bacteria often lack TAs. Further, in
some systems, the cumulative number of TA systems harbored is
positively correlated with the ability to induce the persister state
(Maisonneuve et al., 2011; Fasani and Savageau, 2013; Vogwill
et al., 2016).
Despite extensive research exploring the numerous biological
functions of chromosomal TA systems, their role as selfish
or stabilization elements and in pathogenic stress physiology
is the subject of on-going study. Here we present the largest
intraspecies study of type II TA systems, to our knowledge,
of the opportunistic pathogen Pseudomonas aeruginosa. Some
TA systems have previously been identified from P. aeruginosa
computationally, and found chromosomally and on mobile
elements, either integrated as prophages and ICEs or on plasmids
(Webb et al., 2004; Pandey and Gerdes, 2005; Ramirez-Diaz et al.,
2011; Ou et al., 2012; Bonnin et al., 2013; Li et al., 2016a).
Two systems, HicBA and HigAB, were recently confirmed
experimentally (Li et al., 2016b; Wood and Wood, 2016). We
use a collection of cystic fibrosis (CF) lung isolates that are
longitudinally sampled from Danish patients to follow the
evolution of TA loci in lineages during infection, and compare
them to environmental isolates, in an attempt to determine their
location and function in the accessory genome and subsequently
infer whether they play a role in adaptation to chronic infection
conditions.
With a bioinformatics approach we explore the prevalence of
type II TA systems across P. aeruginosa isolates. The five main
aims are to: (1) Identify the diversity of TA systems and whether
they reside in the core genome or on mobile and/or flexible
genomic islands (GIs); (2) examine whether TA loci acquire
mutations during infection; (3) track changes in the abundance
of systems as strains reside in the lung; (4) screen for whether
there is evidence of horizontal transmission of TA systems
between coexisting clone types; (5) test whether the number and
type of TA systems correlate with how successful strains are at
establishing chronic infections, potentially because of their ability
to form persisters recalcitrant to antibiotic treatment.
MATERIALS AND METHODS
Isolate Collection
We used P. aeruginosa whole genome sequencing of isolates
longitudinally sampled from 33 young Danish CF patients, as
described previously (Marvig et al., 2013, 2015b). Patients were
either infected with one clone type that was sampled repeatedly
over many years, harbored co-occurring clone types, or were
first colonized by one clone type that was replaced by another
with no detected co-occurrence (Marvig et al., 2015a,b). The
collection contained sequence data from 441 isolates of 50
clone types. The genomes of P. aeruginosa from the young
patients were de novo assembled, as described previously (Marvig
et al., 2015a) and are available at the European Nucleotide
Archive, accession number PRJEB5438 (www.ebi.ac.uk/ena). The
genomes were not assembled to one chromosome but were
comprised of multiple contigs (for clinical isolates on average 136
± 274 SD, Table S1), which may result in not all TA systems
being identified. For each contig open reading frames (ORFs)
were predicted with the program Prodigal (Prodigal.ornl.gov;
Hyatt et al., 2010). In addition, we included two transmissible
clone types, DK1 (41 isolates) and DK2 (44 isolates), which
were transmitted between patients from 1973 up to the 1990’s
as previously described (Jelsbak et al., 2007; Yang et al., 2011;
Marvig et al., 2013; Markussen et al., 2014). These were primarily
from older patients with one or a few isolates from each. In
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younger patients, following measures to separate patients in
the clinic, the majority of Danish CF infections are caused
by environmental strains. To test whether TA systems of the
P. aeruginosa that establish CF infection differ from those
that do not, we included 12 environmental isolates collected
from non-infectious sources described in Hilker et al. (2015;
sequences available at ENA accession no. PRJEB4961 and de
novo assemblies kindly provided by J. Klockgether) and Ghoul
et al. (2015; sequences and de novo assemblies available at http://
pubmlst.org/paeruginosa/; accession no. WTCHG-44355_209 to
213). The clone types of environmental isolates were determined
following Marvig et al. (2015b); three were found to overlap with
clone types found in clinical isolates while nine were distinct new
types.
Identification of Putative TA Systems and
Sequence Similarity within Gene Families
De novo genome assemblies of the first isolate of each clone
type from each patient were analyzed to find the number and
family of putative TA loci, for a total of 69 first isolates of 52
clone types from 35 patients, and 12 environmental isolates of
12 different clone types. Putative type II toxin-antitoxin systems
were identified with the program TAfinder (http://202.120.12.
133/TAfinder/index.php; Shao et al., 2011). The cut-off was set at
a score of an average shared identity of the toxin and the antitoxin
at 80% with previously computationally and experimentally
identified TA systems. Systems classified by TAfinder were
subjected to BLASTP analysis to determine conserved domains,
and a BLASTP analysis excluding Pseudomonas hits to see
if they were found, as a pair, in other species. TAfinder
failed to annotate as open reading frames one toxin (HigB)
and one antitoxin (ParD) that had previously been identified.
The antitoxin HigA (PA4674) and the toxin ParE (PA0729)
were collected from the ORF files as described below. The
coding sequences of the unannotated toxin and antitoxin were
identified by a BLASTN search against a local database of
all the clinical isolates, and these were translated to protein
sequences with EMBOSS Transeq (http://www.ebi.ac.uk/Tools/
st/emboss_transeq/) for the first isolate from each clone type. A
third previously identified pair, HicBA, was identified by BLAST
search of the toxin sequence against the de novo assemblies. The
diversity within a given toxin and antitoxin was calculated in
Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/), and
unique protein sequences were identified with GenomeTools
(http://genometools.org/) and compared to known sequences
with BLASTP. The unique sequences were aligned with the
reference sequence from TAfinder with Clustal Omega. Protein
sequences without a 100% identity match were submitted to
GenBank. We refer to all of these putative TA systems as TA
systems, but note that for the majority their function still needs
to be confirmed experimentally.
Location and Neighboring Genes of TA
Systems
The TA systems not found in all isolates were considered to be
part of the accessory genome, on GIs and potentially mobile
elements. The location of TA systems in the P. aeruginosa
accessory genome was determined by BLASTP analysis restricted
to the PAO1 reference genome. We attempted to identify where
GIs were inserted into the core-genome: If a TA pair was found
on a 100 kb contig, the predicted ORFs of the entire contig
were subjected to BLASTP analysis against the reference PAO1
genome. A potential GI insertion site was determined when genes
with high shared identity to genes in PAO1 (>90%) were found
next to genes with lower shared identity (>40%). The insertion
site was confirmed by identifying an upstream gene with high
similarity to a gene in PAO1, neighboring the suspected insertion
site. The inferred insertion sites of GIs were compared to those
identified by Mathee et al. (2008).
Identification of TA Loci Mutations during
Infection
To identify mutations in TA loci acquired during infection we
compared isolates of the same clone type sampled longitudinally
from patients. We aligned de novo assembled contigs of the
region of interest using BLAST align or mapped raw reads
to representative sequences of the clone type. The reads were
mapped to reference sequences with the Burrows-Wheeler
alignment tool (http://bio-bwa.sourceforge.net, version 07.4)
and alignments generated with the paired-end reads or single-
end reads setting, respectively. The alignments were filtered to
remove unmapped reads, sorted and indexed, and assigned to
a read group using Picard Tools (http://picard.sourceforge.net,
version 1.91). Differences between isolates of the same clone
type were identified using Samtools (http://samtools.sourceforge.
net, version 01.19) and mutations manually checked using IGV
(http://www.broadinstitute.org/igv, version 2.3.61).
Rates of Gain and Loss of TA-Bearing GIs
during Infection and on an Ecological Time
Scale
Deletions and insertions of >50 bp in GIs were identified in
the sequence alignments described above. To identify gain of TA
systems during infection we used the first 5–8 amino acids of a
toxin or antitoxin gene, provided by TAfinder, as a search motive
to collect the genes from all isolates from the young patients from
the files with predicted ORFs. The use of these short motives
allowed for discovery of TAs already identified in other isolates
that potentially had been vertically transmitted between clone
types within patients, and the identity of positive hits was verified
by BLASTP search.
Nine clone types found in multiple patients has been
shown not to be transmitted among patients, but independently
acquired by different patients from the environment (Marvig
et al., 2015b; Table S1). To estimate the timescale of gain and
loss of GIs with TAs in the environment we used the variation
in presence of GIs of these isolates. The number of SNPs between
isolates (Marvig et al., 2015b) was used as a measure of time since
the last common ancestor, given an estimated average rate of 2.5
SNPs/year (Yang et al., 2010). The three environmental isolates
of the same clone types as clinical isolates were not included
in this analysis because the sequence coverage was lower, and
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the SNPs identified therefore not reliable (but see Table S2 for
comparisons).
Correlation between TA Systems and
Infection Success
All clone types from the young patients were classified based
on their success in establishing an infection; where “low” was
used for clone types sampled from a patient once, or multiple
times over less than a year (n = 29), “medium” for clone types
sampled multiple times infecting for longer than a year but
either co-occurring with other clone types or being replaced
(n = 16) and “high” for clone types consistently sampled with a
frequency above 80% of sampled isolates from a patient infecting
for more than a year (n = 24). These were compared with the
12 environmental samples. We used 1-Way ANOVA to test if
the number of TA systems were significantly different between
categories and a χ2-test to analyse if the presence of GIs varied
significantly between categories.
RESULTS
Diversity of TA Systems across Isolates
Determined by the Presence of TAs
Residing on GIs
All isolates harbored TA systems, and we found extensive
diversity across the studied isolates. TAfinder identified 32
distinct TA systems, by screening all first sampled isolates of
clone types from all patients (69 isolates of 52 clone types
from 35 patients) and 12 environmental isolates. Of these, 8
antitoxins, 18 toxins, and 7 pairs were verified by BLASTP
analysis, as they produced a specific hit to conserved domains
of toxin or antitoxins. Sixteen T and As had an unspecific hit
to conserved domains of toxin or antitoxins [E < 0.01, Table S3
and Supporting OnlineMaterial (Data Sheet 1)]. For the putative
TAs without a clear match we did a BLASTP analyses with an
Entrez Query specified as toxin or antitoxin, and all except two
shared >27% identity with putative TAs from various species
[Table S3 and Supporting Online Material (Data Sheet 1)].
We classify the TA systems into four groups based on
whether the T and A in a pair are both verified, only one
partner is verified or both unverified: in category 1 both the
toxin and antitoxin were verified by a specific hit by BLASTP
analysis (seven pairs), or experimentally confirmed (two pairs);
in category 2 either the toxin or antitoxin has a specific hit but
the partner does not (10 pairs); in category 3 one partner has
an unspecific hit and the partner does not (seven pairs); and
in category 4 neither were verified (six pairs). These latter six
pairs, however, all had conserved domains that Makarova et al.
(2009) identified as strong candidates for TA systems. Makarova
et al. (2009) suggest that neighboring genes to known T or
As present strong candidates for novel components, and in the
subsequent analyses, we include all pairs from TAfinder where
one or both components were verified by unrestricted BLASTP
analysis. We leave the category 4 pairs out of the subsequent
analyses, althoughwe note that thesemay be functional TAs given
their sequence similarity to putative systems from other species.
For that reason, they are listed in Tables S1, S3 and Figure 1,
and when mentioned in the text referred to as unverified
systems. As further support for the identified pairs being TA
systems, all were also found, as pairs, in a diverse range of
other species (Table S3). Each isolate harbored between 4 and
11 systems of categories 1–3 (mean 5.89 systems ± 1.64 SD,
Table S1). Four TA systems were part of the core genome:
PA1029/PA1030 (Xre/COG5654, category 3), PA1878/PA1879
(Xre/PIN, category 3), PA0124/PA0125 (RHH/RelE, category 2),
and PA4674/ unannotated (HigAB, category 1; Tables 1, 2; found
in all environmental and first sampled clinical isolates, except
one that was missing the HigAB pair). For the Xre/COG5654
and the Xre/PIN systems the toxins were not classified as
such by BLASTP analysis, but the PIN toxin shared 68%
identity with previously identified toxins in the restricted
search. The RHH/RelE and HigAB pairs had been identified
previously (Pandey and Gerdes, 2005), and the latter confirmed
experimentally (Wood and Wood, 2016). All of these core
genome pairs were also found in the P. aeruginosa reference
genomes PA1, PA7, UCBPP-PA14, and LESB58. The other 22 TA
systems varied in prevalence from 1% (found in one clone type
in one isolate) to 65% (1–2 copies in 48 first sampled isolates of
34 CF clone types and 4 environmental isolates). Our analyses
suggest that these are located on GIs with specific insertion sites
(Table S3). Therefore, variation in TA systems across isolates
was caused by those that reside in the accessory genome, on
potentially mobile elements.
The TA loci were categorized by conserved domains, and
for some as belonging to a (super-) family. Based on TAfinders
classification there were six different toxin families/domains,
and eight different antitoxin families/domains represented (and
additionally three unverified toxins and four antitoxins). We
named each TA pair according to the family or domain
(Makarova et al., 2009) as identified by TAfinder, but note
that these are not always identical to the conserved domains
identified by BLASTP (Table S3), and protein length in amino
acids. For each toxin and antitoxin family, 1–15 proteins were
identified (Figure 1; Table 1). All but 12 protein sequences
had a 100% identity match in GenBank (Table S3). The 12
unique sequences were given the accession numbers KY855415-
KY855426. Alignments of the unique sequences to the reference
sequences from TAfinder are available in the Supplementary
Online Material (Data Sheet 1). Three TA systems previously
identified in PAO1 were not annotated by TAfinder. When the
protein sequences of these were analyzed in TAfinder, they shared
67% (HigAB, classified as Xre/RelE by TAfinder, category 1), 72%
(ParDE, classified as PHD/RelE, category 1) and 53% (HicBA,
category 1) identity with pairs recognized by TAfinder. This
suggests that the chosen cut-off at 80% identity is somewhat
conservative and leaves some TA systems unidentified, however,
lowering this obviously increases the risk of including false
positives.
Comparison of the genes flanking TA pairs showed that they
were often highly conserved among clone types, and the GIs
with a given TA pair were in most cases found in one or two
locations in the genome (Tables S1, S3). Many of these insertion
sites have already been identified as sites with “pathogenicity
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FIGURE 1 | Network of toxin and antitoxin associations categorized by family or domain type. Toxins are marked with red and antitoxins blue. Each TA pair is denoted
by a number giving the length of the protein in amino acids and the prevalence in the study population in %. Lines mark the connection between a toxin and its
antitoxin. Bold lines mark TA systems found in the core genome of all isolates. Two TA pairs were named by Pandey and Gerdes (2005), these names are denoted in
parentheses. Pairs identified by TAfinder but not verified by BLASTP analysis are highlighted in green. Seven unique TA pairs were only found in one environmental
isolate (Tables S1, S3) and are not included in the figure.
islands” (Liang et al., 2001; He et al., 2004; Qiu et al., 2006;
Battle et al., 2008) and “regions of genomic plasticity” (Mathee
et al., 2008; Table S3). BLASTP analyses of the GIs showed that
they frequently harbored “mobility genes” such as transposases
and integrases, suggesting that they are, or have been, mobile
elements. The frequently observed PHD/RelE pair (category 1) is
known to reside on the prophage Pf4 (Webb et al., 2004), which
is important for biofilm development (Rice et al., 2009).
We commonly observed two TA pairs on the same GI, as
marked in pink inTable S1. For example, the Xre/RelE 96/99 pair
(category 2) was only found together with RHH/RelE 90/115-140
(category 1), while the latter was alone on a GI in 75% of the clone
types. The AbrB/RelE system (category 1) was sometimes found
in the place of the unverified system Xre/COG5654 208/210
(category 4), with the same flanking genes. This could suggest
that the latter may also be a functional TA pair.
Not all TA pairs were found on contigs long enough to
determine their insertion site in the genome and provide the
full-length sequence of the GI. This was often the case when
two GIs of the same type were present, suggesting that the
presence of highly similar regions hinders de novo genome
assembly. The insertion sites of an “orphan” GI (TA systems
found on a contig with no link to the core genome) could often
be inferred when specific insertion sites for that GI had been
identified for other clone types: If the known insertion sites
were found on separate contigs flanked by GI-specific genes
this was assumed to be the insertion site. In a few cases no
insertion site was identified. It cannot be ruled out that these
TA pairs were found on plasmids, however the sequencing
coverage of these regions were comparable to the average of
the isolates, suggesting that if so they would be low-copy
plasmids.
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TABLE 1 | Overview of TA diversity.
Antitoxin Toxin Size A/T Prevalence % Location A aa % ID T aa % ID Category
RHH relE 75/93 100 CG 98.67–100 94.62–100 Cat2
xre COG5654 122/251 100 CG 99.18–100 96.84–100 Cat3
xre PIN 184/192 100 CG 95.11–100 96.88–100 Cat3
xre (higA) relE (higB) 101/89-92 99 CG 95.05–100 95.65–100 Cat1
RHH relE 90/115-140 65 GI 93.33–100 85.34–100 Cat1
PHD (parD) relE (parE) 83/115 17 GI 100 97.39–100 Cat1
xre relE 96/99 16 GI 100 100 Cat2
abrB relE 105-123/152-154 15 GI 71.43–100 79.05–100 Cat1
xre relE 100/126-127 11 GI 91–100 86.61–100 Cat2
RHH relE 78/111 10 GI 97.30–100 97.2–100 Cat2
RHH PIN 84/139 7* GI 97.62–100 42.88–100 Cat2
COG5606 relE 111/125 5 GI 99.1–100 100 Cat3
vapB PIN 83/131 5 GI 100 100 Cat1
vapB vapC 79/136 5 GI 93.67–100 94.85–100 Cat3
hicB hicA 160-231/59-60 4** GI 62.71–93.22 66.88 Cat1
PHD relE 83/84 4 GI 100 100 Cat1
COG5606 relE 106/120-121 2 GI 97.17 98.33 Cat3
abrB PIN 87/129 1 GI Cat1
COG5606 relE 112/120 1 GI Cat3
hicB hicA 121/91 1 GI Cat2
PHD PIN 77/128 1 GI Cat1
relB relE 90/97 1 GI Cat2
RHH PIN 73/126 1 GI Cat2
RHH relE 78/109 1 GI Cat2
xre hipA 103/429 1 GI Cat2
xre relE 100/117 1 GI Cat3
The first two columns list the gene/domain classes for the antitoxin and toxin pair, followed by the protein length of each in amino acids. Variation in protein length within a class is
denoted by a “–.” For each TA pair its prevalence in % of isolates is stated, followed by its location in either the core genome (CG) or on a genomic island (GI), and for each toxin and
antitoxin the shared amino acid identity within a group is noted. The pairs are classified as category 1–4 dependent on the presence of conserved T and A domains (category 4 are
pairs not included in this table). The toxin and antitoxin classes that have more than two representatives are colored in gray tones. *One toxin appears to be missing antitoxin. **Two out
of four toxins appear to be missing antitoxins. This table is extended in Table S3 with additional information on TA pairs.
TA Loci Acquire Few Mutations during
Infection
In the longitudinal samples, we only observed two mutational
events in core genome TA loci during infection; the complete
loss of a pair as part of a large >40 kb deletion in DK13,
and a non-synonymous SNP in a toxin in one isolate of DK1
(Table 2). All samples of DK21 from one patient had ca. 40
kb insertion disrupting the Xre/COG5654 pair (category 4).
Further, three clone types, that were sampled only once from
a patient and from the environment, harbored stop codons or
an insertion in toxin or antitoxin genes in the core genome
(DK23, DK49, and MG7), and one had an apparent deletion
and insertion covering the HigAB pair (DK28, category 1;
Table 2).
GIs with TA Systems May Be Mobile But
Show Limited Transmission
The mobility of some GIs was supported by the finding of
a circular GI in one patient: the GI comprised an individual
contig, where the end-genes were found in the middle, and the
core genome flanking genes were found next to each other on
a separate contig (RHH/RelE 90/115-140, DK11, category 1).
Further, two GIs with unverified TA systems were found to
double their copy number during infection (Table 2). However,
we found no evidence for horizontal transmission of GIs with TA
systems between clone types within patients. When clone types
co-occurring in a patient shared a GI type and TA system, the
sequences had >50 SNPs, which would not be expected if they
had been transmitted recently, given the average rate of mutation
of 2.5 SNPs/year (Marvig et al., 2013).
Transmission between patients is evident for three clone types,
DK6, DK15 and DK26 (Marvig et al., 2015b; Table S1), where
the GIs with TA systems were identical for DK6 and DK15. For
DK26, isolates from one patient (P99F4) showed an apparent
acquisition of a >212 kb GI not found in other isolates, with a
TA pair (COG5606/RelE 111/125, category 3) found in two other
clone types. In another patient with DK26 (P92F3), there was a
duplication of an already present GI with an unverified TA pair,
as mentioned above (Table 2; Table S1).
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TABLE 2 | Mutations in TA systems.
Event TA loci Loc. Mut. Clone
type
Patient Isolate Est. del. Infection
age
Comment
Insertion in antitoxin xre/COG5654 CG 2C DK23 P22M4 177 0 years Isolate sampled as one-off,
toxin likely functional
Insertion in toxin xre/COG5654 CG DK21 P22M4 All 40 kb insertion with
phage-like genes
Ns snp in toxin xre/relE (higAB) CG C61T DK01 P28F1 2009 36 years
Deletion of TA pair xre/relE (higAB) CG DK28 P96F4 202 1.6 kb 0 years Isolate sampled as one-off
Deletion of TA pair xre/PIN CG DK13 P05M4 117 >40 kb 2.4 years
Stop codon in antitoxin xre/PIN CG T291A Env. MG7 Toxin likely functional
Stop codon in antitoxin xre/PIN CG T291A DK49 P72F4 341 0 years Isolate sampled as one-off,
toxin likely functional
Ns snp in antitoxin xre/GNAT CG A439G DK36 P77F4 400 2.73 years
Partial loss of GI, TA lost COG5642/COG5654 GI DK26 P92F3 268,
273–275
105.5 kb 0.35 year
Partial loss of GI, TA remains PHD/relE (parDE) GI DK24 P22M4 183 43 kb 0.17 year
Partial loss of GI, TA remains abrB/relE & merR/PIN GI DK36 P77F4 403 53.4 kb 2.73 years
Complete loss of GI RHH/relE 90/115-140 GI DK44 P70F4 334 81 kb 1.06 years
Complete loss of GI RHH/relE 90/115-140 GI DK02 P06M2 2002 90.6 kb 29 years Hypermutator
Complete loss of GI RHH/relE 90/115-140 GI DK02 P11M2 2006b 90.6 kb 33 years Hypermutator
Complete loss of GI RHH/relE 90/115-140 GI DK02 P40F2 2002 90.6 kb 29 years
Complete loss of GI RHH/relE 90/115-140 GI DK02 P43M2 2002 90.6 kb 29 years Hypermutator
Loss of one out of two GIs RHH/relE 90/115-140 GI IT11 P55M4 440 89.1 kb 0.79 year
Partial loss of GI, TA remains RHH/relE 90/115-140 GI DK03 P62M4 All but one
isolate
40 kb
Partial loss of GI, TA remains RHH/relE 90/115-140 GI DK36 P77F4 All but 410,
410.1
50 bp 0.83 year Integrase deleted
Duplication of GI xre/COG5654 & merR/PIN GI DK26 P92F3 All
Duplication of GI xre/COG5654 & merR/PIN GI DK21 P22M4 181, 182 1.06 years
Partial loss of GI, TA remains xre/COG5654 & merR/PIN GI DK02 P14F1 1973 24 kb >1 year
Partial loss of GI, TA remains HEPN/MNT GI DK02 P43M2 2002 5 kb 29 years
Partial loss of GI, TA remains HEPN/MNT GI DK02 P33F3 2003.a,
2003.b
>100 kb 30 years Part of the CG also deleted
Partial loss of GI, TA remains HEPN/MNT GI DK02 P80F1,
P11M2
2002.b,
2006.b
18 kb 29 years
List of mutations observed in longitudinally sampled clone types and stop codons observed in clinical and environmental (env.) isolates. The location of a TA pair is given as core genome
(CG) or on a genomic island (GI) and the mutation as the nucleotide change within the gene. For deletions, the estimated length in kb is noted, and for each mutation the length of
infection of the clone type at sampling time. Stop codons were observed in three antitoxins that were sampled only once for that clone type from two patients and an environmental
isolate. The toxins of the antitoxins with stop codons and an insertion were likely still functional, as their sequences were identical to those from other isolates. TA pairs that were identified
by TAfinder but not verified by BLASTP analysis are highlighted with green.
GIs with TA Systems Are More Frequently
Lost Than Gained during Infection
Complete or partial loss of GIs carrying TA systems during
infection was observed 15 times in the sample population, in 7
out of 52 clone types. One isolate of IT11 lost a GI, that is present
in two copies in the other isolates from the patient. In four isolates
of the transmissible DK2 clone type, we observed the complete
excision of the most common GI (with RHH/RelE 90/115-140,
category 1) in four independent events, after 29 (three isolates)
and 33 (one isolate) years of infection, respectively. This GI was
also lost in one isolate of DK44. Partial loss of a GI including two
unverified TA systems occurred once in DK26. However, there
were eight events in four clonetypes, where TA systems remained
despite partial loss of a GI, in an isolate of DK3, an isolate of
DK24, two isolates of DK36 and four isolates of DK2 (unverified
category 4 pairs; Table 2).
To estimate the rate of loss and gain of GIs with TA systems
on an ecological time scale, we used the nine clone types that
had been independently acquired by multiple patients from the
environment. For these we had information on the number of
SNPs in the core genome differentiating them (Marvig et al.,
2015b). As an example, for clone type DK6, the isolates most
closely related to each other, sampled from two patients, are
separated by 421 SNPs (∼168 years). Three GIs are only present
in one of the DK6 lines giving an estimated rate of 0.033 losses
or gains of GIs per year, or one event per 30.4 years. This gives
us 11 independent estimates of gain and loss of GIs, as two
clone types contributed two data points each (Table S2). We
Frontiers in Microbiology | www.frontiersin.org 7 June 2017 | Volume 8 | Article 1180
Andersen et al. Type II Toxin-Antitoxin Systems of P. aeruginosa
recorded between 0 and 6 events that had occurred over an
estimated 21.6–201.6 years. This lead to on average one loss or
gain every 52.69 ± 42.21 years std. dev. and a range between
an event every 9.9–151.6 years (excluding the data point with 0
events).
Correlation between TA Systems on GIs
and the Ability to Establish Chronic
Infection
There was no significant difference in the number of TA systems
of a clone type and its ability to establish a chronic infection, as
defined in the Materials and Methods (One-Way ANOVA, df =
3; 33.67; F = 0.65, p = 0.59). The most commonly occurring
RHH/RelE 90/115-140 TA system (category 1) residing on GIs
was, however, found more often in clinical isolates compared to
environmental isolates (70% of first clinical isolates compared to
33% of environmental, χ2 = 4.4, df = 1, p< 0.05, with the caveat
of a small sample size of environmental isolates). Prevalence of
the RHH/RelE 90/115-140 TA system across different categories
of clinical isolates was similar, ranging from 64 to 75%.
DISCUSSION
We present, to our knowledge, the largest study of intraspecies
diversity of type II TA systems, in clinical isolates of
P. aeruginosa. The systems were identified computationally
with the program TAfinder and subsequently verified by
determination of conserved domains. The pairs were split into
four categories of TA systems based on the likelihood that these
are functional TA systems. Such variation highlights the inherent
risk of relying on a computational approach, and emphasizes
the need for experimental validation. However, the aim of our
study is a broad analysis of a large collection that will serve as
a precursor to experimental work, and therefore we include all
genes that are already verified or identified as novel putative
TA systems. In support of this stance we found that for the
two experimentally confirmed systems, the HigB toxin and the
HicB antitoxin did not have specific hits as such in the BLASTP
analysis. We also note that more toxins were verified than
antitoxins, perhaps suggesting a greater diversity in the latter.
We clearly distinguish between TA systems found in the core
genome and on GIs. The core genome harbors four TA pairs,
while 22 other pairs are on GIs and variably found across isolates,
responsible for the diversity of TA systems in the population. It is
unclear if the core genome TA systems have been “domesticated”
from mobile elements or have evolved within P. aeruginosa, but
the former seems possible as they were also found in other non-
Pseudomonas species (Table S3). We do not find a correlation
between the number of TA systems an isolate harbors and its
ability to establish as a chronic infection.
The function of TA systems in P. aeruginosa, and in particular
in infection, is relatively unexplored. Recently, two pairs were
experimentally confirmed to be TA systems, the core genome
HigAB pair (Wood and Wood, 2016) and the HicBA pair found
on a GI (Li et al., 2016b). For HigAB, deletion of the antitoxin
gene higA results in reduced growth, swarming and biofilm
formation, and a decrease in production of pyocyanin and
pyochelin, all of which are phenotypes affecting virulence. The
HicBA pair was found to have a bacteriostatic effect and cause cell
aggregation. However, a knock-out of hicBA did not affect biofilm
formation or infectivity in an acute mouse-infection model (Li
et al., 2016b). Contrary to our study, the prevalence reported in
the Li et al. (2016b) study of the HicBA (33% of 996 isolates
screened) wasmuch higher than that observed here (4%, of which
only two toxins out of four appear to have an antitoxin), for
unknown reasons. On the other hand, the HigAB (category 1)
and the RHH/RelE (category 2) core genome pairs and one GI
TA pair (PHD/RelE or ParDE, category 1) have been found to
be expressed in CF sputum, suggesting they may play a role in
infection (Williams et al., 2011).
GI-Residing and Core Genome TA Systems
Are Stable in Clinical and Environmental
Isolates
We observed few mutations in the core genome TA loci during
infection. Notably, the few isolates with stop-codons and an
insertion in core genome antitoxins were not successful at
establishing infection, as they were either found as clone types
only sampled once or from an environmental isolate. Two
of these, interestingly, had the same mutation introducing a
stop codon (Table S3). This corresponds with other studies
(Mine et al., 2009) where TA loci are not acquiring loss of
function mutations and, therefore, are not selected against but
maintained as selfish elements or for other physiological cellular
processes.
Complete or partial loss of GIs during infection was
rare, suggesting that they are beneficial pathogenicity islands
facilitating host colonization (He et al., 2004) and/or that TA
systems are successful at stabilizing them. In six out of 15 cases
an entire GI was lost, and because these were found in the same
locations as documented ICEs this may represent active excision
of mobile elements. Excision may be a way for the ICE to “jump
ship” in search of a new host in the event of cell damage. This was
seen in Pseudomonas knackmussi where the fraction of the cell
population in an ICE “transfer-competent” state increased in the
presence of reactive oxygen species and cell damage (Reinhard
and van der Meer, 2014). In eight of the nine partial losses of
GIs, the TA systems were intact, which could indicate that TAs
can stabilize a part if not all of a GI. Even though pathogenicity
islands are well-documented to be beneficial during infection (He
et al., 2004; Battle et al., 2008), horizontal transfer of these or
other GIs was not observed between clone types within patients.
This may reflect that infecting isolates already have the GIs
they need or that spatial segregation of co-occurring clone types
within the lung and sinus environment limits the possibility for
transfer.
To evaluate the stability of GIs in patients, we used the
variation in TA-bearing GIs within clone types that had been
independently acquired from the environment to estimate the
rate of loss and gain of these on an ecological timescale. This
gave an estimate of one loss or gain of a GI every 53 years.
There are some obvious caveats with this estimate: the number
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of SNPs in the core genome only provides a rough estimate of
the time since the last common ancestor, and GIs may have been
lost and acquired repeatedly in the time between sampling of
the compared isolates. That said, the estimate of one event per
53 years is in line with what we observe in the clinical isolates
where loss occurs rarely: in the longest sampled clone type, DK2,
we recorded losses only four times after 29 and 33 years of
infection (Table 2; three of these deletions occurred in isolates
with an increased mutation rate, so-called hypermutators with a
mutation rate >3.6 times higher than the other isolates (Marvig
et al., 2013). Comparable stability of GIs in the environment
and in patients suggests that they are not only maintained
for pathogenesis, and further supports a stabilizing effect
of TAs.
TA Systems and Bacterial Pathogenesis
Our findings show that within P. aeruginosa there is no
correlation between an incremental number of TA systems
and the ability to establish a chronic infection. Previous work
in S. typhimurium and E. coli have shown an association
between certain TA systems as well as a correlation between
the cumulative number of TA systems and level of persistence
(Maisonneuve et al., 2011; Helaine and Kugelberg, 2014; Helaine
et al., 2014) and there is a strong correlation between the two
across eight Pseudomonas species (Vogwill et al., 2016). They
have also been implicated in inducing biofilm formation in E.
coli and enhancing host virulence inH. influenza, Mycobacterium
tuberculosis, and S. typhimuriun (Lobato-Marquez et al., 2015),
and inducing persistence in the development of recalcitrant
infections in P. aeruginosa (Mulcahy et al., 2010).
We find that GIs with the RHH/RelE 90/115-140 TA
pair were found significantly more frequently in clinical
than environmental isolates, supporting a correlation between
infectivity and these TA-bearing GIs. They were found at two
insertion hotspots where multiple pathogenicity islands have
been described (in the intergenic regions PA0976//PA0988 and
PA4541//PA4542; Table S3), from which some genes have been
shown to affect virulence in infection models (He et al., 2004;
Battle et al., 2008). The GIs sharing these insertion sites are
likely mosaic in nature, with recombination occurring within and
between isolates, and even between species (Larbig et al., 2002; He
et al., 2004). A similar pattern of some specific TAs being found
more often in pathogenic isolates has been observed in the related
Pseudomonas putida (Molina et al., 2016).
Our results suggest that some TA systems in P. aeruginosa
may serve in the maintenance of GIs and do not appear to play a
role in persistence or may not even be functional. P. aeruginosa
is highly versatile and ubiquitous in the environment, as well
as an opportunistic pathogen (Stover et al., 2000). Therefore,
it may rely on a baseline number of TA systems, to mediate
stress responses while colonizing/infecting a diverse range of
environments and host types with variable abiotic conditions.
If so, harboring additional TA systems may not provide greater
benefits to strains, specifically in infection compared to other
environments, and the core genome TA systems could be all that
is needed.
CONCLUSIONS
Screening for the prevalence of TA systems has become a popular
pursuit (Pandey and Gerdes, 2005; Sevin and Barloy-Hubler,
2007; Leplae et al., 2011; Shao et al., 2011), as chromosomal type
II TA systems were discovered to play a role in the regulation
of cell metabolism, particularly for persister cell formation
(Kim and Wood, 2010; Maisonneuve et al., 2011; Fernandez-
Garcia et al., 2016). Although extensive research has explored
the numerous biological functions proposed for chromosomal
TA systems, their role as selfish, stabilizing elements, and in
bacterial stress response is still open to debate. While our
work highlights the importance of localizing, rather than simply
counting TA systems it should be noted that their location in the
genome does not limit them to specified functions. In addition,
their potential function as stress response elements does not
exclude stabilization properties, emphasizing that studiesmust be
cautious in assigning single functions. While the majority of TA
systems identified here remain to be confirmed experimentally,
our study is the first to track putative TA systems over time in
a clinical system and we show they are remarkably stable, both
when found in the core genome and on GIs. A key finding of
this study is the discovery of a set of core TAs, irrespective of
where the isolates were sampled. These may play a role in the
regulatory network of P. aeruginosa; enhancing survival across
fluctuating environmental conditions and during adaptation in
a host. The next step will be to experimentally test such a
regulatory role, particularly in pathogenic P. aeruginosa isolates
in the development of persister cells contributing to recalcitrant
infections.
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Table S1 | Overview of TA prevalence in P. aeruginosa isolates. For each isolate is
stated whether it comes from a CF patient or the environment, its clone type, the
total number of TA systems (including four core genome pairs), the isolate number
(as listed in Marvig et al., 2015b), the clone type’s persistence in the patient,
whether the clone type had been transmitted between patients and the number of
contigs in the de novo assembled genome. Subsequently all TA pairs found on
genomic islands are listed, and their prevalence in an isolate marked followed by
the observed or predicted location of the genomic island. TA pairs marked in pink
within an isolate are found on the same GI. Columns in green show TA pairs
identified by TAfinder but not verified by BLASTP analysis (category 4 pairs).
Table S2 | Estimation of the frequency of loss and gain of GIs with TA pairs in the
environment. Some clonetypes found in multiple CF patients had been
independently acquired from the environment. We identified the lowest possible
number of events of loss or gain of GIs between two isolates of the same clone
type as the difference in GIs, and estimated the time since the most recent
common ancestor by the number of SNPs in the whole genome (Marvig et al.,
2015b) and an average rate of 2.5 SNPs accumulating per year in the CF
environment (Yang et al., 2011). From this we calculated the frequency in years of
gain and loss of GIs. Below are comparisons with the three environmental isolates
that shared clonetypes with the clinical isolates. These were not included in the
analyses as the sequence coverage was lower and hence the calculated SNPs
may be unreliable.
Table S3 | Extended overview of TA diversity. This table adds to Table 1 by
including the location in the genome of TA pairs and that of the genomic islands
on which they reside, and where these have previously been described. TA names
in green show pairs identified by TAfinder but not verified by BLASTP analyses.
Conserved domains of TAs found by unrestricted BLASTP analyses are listed,
yellow mark a specific hit and white an unspecific hit (see SOM). When these
could not be verified, BLASTP analyses restricted to toxin or antitoxin was
performed and the % shared identity to putative TAs is listed (blue highlight, see
SOM). Domains without a match by unrestricted BLASTP analyses but predicted
to be likely TAs by Makarova et al. (2009) are highlighted in purple. The pairs are
classified as category 1-4 dependent on the presence of conserved T and A
domains. The number of unique protein sequences identified in the study is
shown, and if these were identical to previously identified sequences the GenBank
accession number is listed. Twelve sequences did not have a 100% identity match
and were submitted to GenBank (accession numbers KY855415-KY855426). For
each pair it is listed which species they are also found in, as pairs. For all but two
core genome pairs, Xre/GNAT and Xre/RelE (HigAB), three alternative TA “host
species” are listed in the non-exhaustive list, as well as their % shared identity with
the pair of our study.
Data Sheet 1 | Supporting online material (Data Sheet 1): Alignments for each
toxin and antitoxin, with the unique sequence(s) and the reference from TAfinder,
denoted as “ref” and by the acquisition number from GenBank. Alignments are
followed by the results for conserved domains from an unrestricted BLASTP
search, or the top hits from a BLASTP search with Entrez Query restricted to
“toxin” or “antitoxin.” In two instances neither gave a significant hit (COG5654 251
& 210).
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